LCWP
TMO icon

Legacy Capital Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Capital Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Sell
564
-428
-43% -$205K 0.05% 301
2026
Q1 		$488K Sell
992
-335
-25% -$182K 0.1% 214
2025
Q4 		$769K Sell
1,327
-51
-4% -$28.8K 0.17% 132
2025
Q3 		$668K Buy
1,378
+431
+46% +$201K 0.15% 154
2025
Q2 		$384K Sell
947
-262
-22% -$110K 0.09% 257
2025
Q1 		$602K Sell
1,209
-433
-26% -$235K 0.15% 148
2024
Q4 		$854K Sell
1,642
-70
-4% -$38.5K 0.21% 96
2024
Q3 		$1.06M Sell
1,712
-71
-4% -$42K 0.21% 101
2024
Q2 		$986K Buy
+1,783
New +$1.02M 0.25% 80
2024
Q1 		– Sell
-1,885
Closed -$1M – 322
2023
Q4 		$1M Buy
1,885
+218
+13% +$106K 0.28% 80
2023
Q3 		$844K Buy
+1,667
New +$888K 0.23% 89
2023
Q2 		– Sell
-1,560
Closed -$899K – 219
2023
Q1 		$899K Buy
+1,560
New +$879K 0.25% 87
2021
Q1 		– Sell
-399
Closed -$186K – 103
2020
Q4 		$186K Buy
+399
New +$187K 0.08% 77

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legacy Capital Wealth Partners's TMO Position: Q2 2026 in Review

Legacy Capital Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 43% in Q2 2026, selling an estimated $205K and leaving 564 shares worth $283K. The position accounts for 0.05% of the portfolio, ranked #301.

Legacy Capital Wealth Partners first reported a position in TMO in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.06M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Legacy Capital Wealth Partners held 564 shares of Thermo Fisher Scientific worth $283K as of Q2 2026.
  • Legacy Capital Wealth Partners sold 428 Thermo Fisher Scientific shares in Q2 2026, an estimated $205K.
  • Thermo Fisher Scientific made up 0.05% of Legacy Capital Wealth Partners's portfolio in Q2 2026, its #301 holding.
  • Legacy Capital Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 13 quarters since.
  • Legacy Capital Wealth Partners's Thermo Fisher Scientific position peaked at $1.06M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Legacy Capital Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.